Founded with a mission to enhance human life through biomedical innovation, Maravai LifeSciences Holdings focuses on providing essential reagents and technologies for nucleic acid production and biologics safety testing. The company supports biotech, biopharma, and life science companies globally, enabling the development of novel vaccines, therapeutics, and diagnostics. Maravai's portfolio includes market-leading brands that act as catalysts for scientific breakthroughs, ensuring a reliable supply of high-quality products for critical research and development.

Maravai LifeSciences has garnered support from notable investors and industry leaders, contributing to its rapid growth and significant impact on the life sciences sector. The company's proprietary technologies have been instrumental in advancing biomedical research, particularly in the areas of vaccine development and therapeutic innovation. By working closely with customers throughout all phases of discovery and process development, Maravai has established itself as a key player in the global effort to improve human health through science.